Modifiers of calcium oxalate crystallization found in urine. I. Studies with a continuous crystallizer using an artificial urine
- PMID: 2423714
- DOI: 10.1016/s0022-5347(17)46084-8
Modifiers of calcium oxalate crystallization found in urine. I. Studies with a continuous crystallizer using an artificial urine
Abstract
Various modifiers of the rate of crystallization of calcium oxalate (CaOx) known to be present in urine were studied in a continuous crystallizer system under conditions approximating those in whole urine. Of the small ions examined, magnesium and citrate were only weak inhibitors of the crystal growth rate and degree of agglomeration of CaOx within the urinary range of concentration of these ions. At and beyond the upper limit of the normal, however, both ions became much more active mainly through their ability to complex oxalate and calcium ions respectively. Pyrophosphate showed similar characteristics although its ability to act as an inhibitor at high concentrations was not due to complexation of calcium ions but to adsorption onto the crystal surface of the freshly generated CaOx crystals. The polyanionic inhibitors, chondroitin-4-sulphate, heparin and ribonucleic acid (RNA), also acted as adsorption inhibitors of growth and agglomeration. Of all the inhibitors tested RNA was the most active within the concentration range found in normal urine. Under the conditions of ionic strength employed, it was not possible to measure the effect of Tamm-Horsfall mucoprotein satisfactorily since it polymerized to form particles sufficiently large to interfere with the true crystal counts of CaOx in the test system.
Similar articles
-
Modifiers of calcium oxalate crystallization found in urine. II. Studies on their mode of action in an artificial urine.J Urol. 1986 Jul;136(1):128-31. doi: 10.1016/s0022-5347(17)44756-2. J Urol. 1986. PMID: 3012126
-
Magnesium, citrate, magnesium citrate and magnesium-alkali citrate as modulators of calcium oxalate crystallization in urine: observations in patients with recurrent idiopathic calcium urolithiasis.Urol Res. 1999 Apr;27(2):117-26. doi: 10.1007/s002400050097. Urol Res. 1999. PMID: 10424393 Clinical Trial.
-
Modulation of calcium oxalate monohydrate crystallization kinetics in vitro.Kidney Int. 1988 Sep;34(3):346-50. doi: 10.1038/ki.1988.187. Kidney Int. 1988. PMID: 2459439
-
[Experimental studies on the effect of inhibitors of crystallization in the urine].Z Urol Nephrol. 1979 May;72(5):383-90. Z Urol Nephrol. 1979. PMID: 225904 Review. German. No abstract available.
-
Defenses of an unstable compromise: crystallization inhibitors and the kidney's role in mineral regulation.Kidney Int. 1990 Oct;38(4):625-31. doi: 10.1038/ki.1990.252. Kidney Int. 1990. PMID: 2232503 Review. No abstract available.
Cited by
-
Glycosaminoglycans, uric acid and calcium oxalate urolithiasis.Urol Res. 1991;19(6):375-80. doi: 10.1007/BF00310153. Urol Res. 1991. PMID: 1759332
-
Kidney stones.Nat Rev Dis Primers. 2016 Feb 25;2:16008. doi: 10.1038/nrdp.2016.8. Nat Rev Dis Primers. 2016. PMID: 27188687 Free PMC article. Review.
-
Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation.World J Urol. 1997;15(3):155-64. doi: 10.1007/BF02201852. World J Urol. 1997. PMID: 9228722 Review. No abstract available.
-
Acid Stimulation of the Citrate Transporter NaDC-1 Requires Pyk2 and ERK1/2 Signaling Pathways.J Am Soc Nephrol. 2018 Jun;29(6):1720-1730. doi: 10.1681/ASN.2017121268. Epub 2018 Apr 20. J Am Soc Nephrol. 2018. PMID: 29678998 Free PMC article.
-
Studies on the crystallization of magnesium ammonium phosphate in urine.Urol Res. 1990;18(6):401-6. doi: 10.1007/BF00297373. Urol Res. 1990. PMID: 2100416
MeSH terms
Substances
LinkOut - more resources
Full Text Sources